---

$0.57

-0.0205 ( -3.48% ) 175.8K

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-04-05	Sale	-129450.00	HOLUBIAK MYRON Z
2024-04-05	Sale	-1165048.00	Mazur Leonard L
2024-03-18	Sale	-75000.00	Smith Robert Joseph
2023-10-12	Sale	-75000.00	Webb Carol
2023-10-12	Sale	-300000.00	Czuczman Myron
2023-10-12	Sale	-400000.00	HOLUBIAK MYRON Z
2023-10-12	Sale	-75000.00	Holuka Eugene Myron
2023-10-12	Sale	-75000.00	Dutia Suren G
2023-10-12	Sale	-300000.00	Bartushak Jaime
2023-10-12	Sale	-75000.00	MCGRATH DENNIS M